EUVIMEDEUVIMED entdecken
Crossref

The regulation of cannabis-based medicinal products across jurisdictions

Olivier Reisch, David Alexandre, Michèle Büchler

Pin Code · 2020

DOI: 10.3917/pinc.003.0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pin Code, 2020. Verfasst von Olivier Reisch und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabis-based medicinal products are often referred to as “cannabis-based products for medicinal use in humans” and will, for the purposes of this article, be referred to as CBPMs hereafter. CBPMs are today authorized to be administered as a medicine in many countries, including Luxembourg. In view of the above, we consider the current state of the legislation and distribution of CBPMs across multiple jurisdictions around the world, such as Australia, Austria, Canada, Denmark, Germany, Italy, Luxembourg, the Netherlands, Poland, Spain and the United Kingdom. The law referred to in this article is accurate as at 28 January 2020. The legal framework relating to the regulation of CBPMs is under regular review in a number of jurisdictions and therefore subject to change. The contents of this article do not contain, nor consist in, any legal advice.

Zitieren

APA

Reisch, O., Alexandre, D., & Büchler, M. (2020). The regulation of cannabis-based medicinal products across jurisdictions. Pin Code. https://doi.org/10.3917/pinc.003.0002

Vancouver

Reisch O, Alexandre D, Büchler M. The regulation of cannabis-based medicinal products across jurisdictions. Pin Code. 2020. doi:10.3917/pinc.003.0002

BibTeX
@article{Reisch2020,
  author = {Reisch, Olivier and Alexandre, David and Büchler, Michèle},
  title = {The regulation of cannabis-based medicinal products across jurisdictions},
  journal = {Pin Code},
  year = {2020},
  doi = {10.3917/pinc.003.0002}
}
Kostenlos starten →